Symptomatic and asymptomatic visual loss in patients taking vigabatrin

Ophthalmology

Volumn 106, Issue 9, 1999, Pages 1792-1798

  Danesvar, Hossein ^a   Racette, Lyne ^a   Coupland, Stuart G ^a   Kertes, Peter J ^a   Guberman, Alan ^b   Zackon, David ^a  

^a UNIVERSITY OF OTTAWA EYE INSTITUTE   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

VIGABATRIN;

ADULT; ARTICLE; CLINICAL ARTICLE; ELECTROOCULOGRAPHY; ELECTRORETINOGRAPHY; EVOKED VISUAL RESPONSE; EYE FUNDUS; FEMALE; HUMAN; MALE; PERIMETRY; PRIORITY JOURNAL; VISUAL ACUITY; VISUAL FIELD; VISUAL IMPAIRMENT;

EID: 0033505364     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0161-6420(99)90345-7     Document Type: Article

References (29)

1. Guberman A. Vigabatrin. Can J Neurol Sci 1996;23(Suppl 2):S13-17.
2. Marson AG, Kadir ZA, Hutton JL, Chadwick DW. The new antiepileptic drugs: a systematic review of their efficacy and tolerability. Epilepsia 1997;38:859-80.
3. Jung ML, Palfreyman MG. Vigabatrin: mechanisms of action. In: Levy RH, Mattson RH, Meldrum BS, eds. Antiepileptic Drugs, Fourth Edition. New York: Raven Press, 1995;903-13.
4. Elke T, Talbot JF, Lawden MC. Severe persistent visual field constriction associated with vigabatrin. Br Med J 1997;314: 180-1.
5. Wilson EA, Brodie MJ. Severe persistent visual field constriction associated with vigabatrin [letter]. Br Med J 1997;314:1693.
6. Wong ICK, Mawer GE, Sander JWAS. Severe persistent visual field constriction associated with vigabatrin [letter]. Br Med J 1997;314:1693-4.
7. Blackwell N, Hayllar J, Kelly G. Severe persistent visual field constriction associated with vigabatrin [letter]. Br Med J 1997; 314:1694.
8. Harding GA. Severe persistent visual field constriction associated with vigabatrin [letter]. Br Med J 1997;314:1694.
9. Krauss GL, Johnson MA, Miller NR. Vigabatrin-associated retinal cone system dysfunction: electroretinogram and ophthalmologic findings. Neurology 1998;50:614-8.
10. Ruether K, Pung T, Kellner U, et al. Electrophysiologic evaluation of a patient with peripheral visual field contraction associated with vigabatrin. Arch Ophthalmol 1998;116:817-9.
11. Johnson CA, Adams AJ, Casson EJ, Brandt JD. Blue-on-yellow perimetry can predict the development of glaucomatous visual field loss. Arch Ophthalmol 1993;111:645-50.
12. Johnson CA, Adams AJ, Casson EJ, Brandt JD. Progression of early glaucomatous visual field loss as detected by blue-on-yellow and standard white-on-white automated perimetry. Arch Ophthalmol 1993;111:651-6.
13. Johnson CA, Adams AJ, Twelker JD, Quigg JM. Age-related changes in the central visual field for short-wavelength-sensitive pathways. J Opt Soc Am A 1988;5:2131-9.
14. Kriss A, Jeffrey B, Taylor D. The electroretinogram in infants and young children. J Clin Neurophysiol 1992;9:373-93.
15. Coupland SG, Janaky M. ERG electrode in pediatric patients: comparison of DTL fiber, PVA-gel, and non-corneal skin electrodes. Doc Ophthalmol 1989;71:427-33.
16. Marmor MF, Zrenner E. Standard for Clinical Electro-oculography. International Society for Clinical Electrophysiology of Vision. Arch Ophthalmol 1993;111:601-4.
17. Mackenzie R, Klistorner A. Severe persistent visual field constriction associated with vigabatrin. Asymptomatic as well as symptomatic defects occur with vigabatrin [letter]. Br Med J 1997;316:233.
18. Mustafa BA. Diversity of GABA receptors in the vertebrate outer retina. Trends Neurosci 1995;18:118-20.
19. Pow DV, Baldridge W, Crook DK. Activity-dependent transport of GABA analogues into specific cell types demonstrated at high resolution using a novel immunocytochemical strategy. Neuroscience 1996;73:1129-43.
20. Butler WH. The neuropathology of vigabatrin. Epilepsia 1989; 30(Suppl 3):S15-17.
21. Neal MJ, Cunningham JR, Shah MA, Yazulla S. Immunocytochemical evidence that vigabatrin in rats causes GABA accumulation in glial cells of the retina. Neurosci Lett 1989; 98:29-32.
22. Elder MJ. Diazepam and its effects on visual fields. Aust N Z J Ophthalmol 1992;20:267-70.
23. Masland RH. Amacrine cells. Trends Neurosci 1988;11:405-10.
24. C receptors to rod and cone bipolar cells in a rat retinal slice preparation. J Neurophys 1998;79:1384-95.
25. Miller RTF, Dowling JE. Intracellular responses of the Müller (glial) cells of mudpuppy retina: their relation to b-wave of the electroretinogram. J Neurophysiol 1970;33:323-41.
26. Newman E, Reichenbach A. The Müller cell: a functional element of the retina. Trends Neurosci 1996;19:307-12.
27. Distler C, Dreher Z. Glia cells of the monkey retina-II. Müller cells. Vision Res 1996;36:2381-94.
28. Newman EA, Zahs KR. Modulation of neuronal activity by glial cells in the retina. J Neurosci 1998;18:4022-8.
29. Backstrom JT, Hinkle RL, Flicker MR. Severe persistent visual field constriction associated with vigabatrin. Manufacturers have started several studies [letter]. Br Med J 1997;314: 1694-5.